>中东和非洲临床实验室服务市场，按专业（临床化学测试、血液学测试、 微生物学测试、免疫学测试、滥用药物测试、细胞学测试和基因测试）、提供商（独立和参考实验室、医院实验室和护理和医生办公室实验室）、应用（药物发现相关服务、药物开发相关服务、生物分析和实验室化学服务、毒理学测试服务、细胞和基因治疗相关服务、临床前和临床试验相关服务和其他临床实验室服务）、服务类型（常规测试服务、深奥服务和解剖病理学服务）、国家（巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列和中东和非洲其他地区）行业趋势和预测到 2028 年。
市场分析和洞察：中东和非洲临床实验室服务市场
临床实验室服务市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析，在 2021 年至 2028 年的预测期内，该市场以 4.7% 的复合年增长率增长，预计到 2028 年将达到 75.5156 亿美元。全球传染病的增加和临床诊断方法的进步推动了中东和非洲临床实验室服务市场的增长。
临床实验室是医疗保健领域的重要组成部分。大多数诊断测试（从血液测试到基因分析）都是在这些临床实验室中进行的，以检测不同的疾病。临床实验室提供数据和资源，以优化医疗保健系统中所需的分配，例如诊断和测试结果。这可以维护并提供可靠且正确的测试结果，使医生能够在各个级别的医疗保健服务中做出适当的临床和诊断决策。这允许临床医生调整、开始和停止治疗，而如果没有医疗实验室设施，治疗将受到阻碍。临床实验室服务包括药物发现、药物开发、生物分析和实验室化学、毒理学测试、细胞和基因治疗以及临床前和临床试验相关服务。独立和参考实验室、医院实验室、护理和医生办公室实验室是临床实验室服务的一些主要提供者。
中东和非洲临床实验室服务市场的增长反映了传染病发病率的上升、对早期和准确疾病诊断的需求不断增长以及临床诊断方法的进步。此外，未来有望促进中东和非洲临床实验室服务市场增长的主要因素包括数字病理学平台的采用率不断提高、对临床实验室提供的全面健康检查的偏好。检测结果不准确以及报销政策不完善预计将抑制中东和非洲临床实验室服务市场的增长。然而，医疗支付方和提供者面临的价格压力以及对家庭/即时检测程序的偏好增加预计将阻碍市场增长。
临床实验室服务市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和临床实验室服务市场情况，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预期目标。
临床实验室服务市场范围和市场规模
临床实验室服务市场按专业、提供商、应用和服务类型进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据专业领域，市场细分为临床化学检测、血液学检测、微生物学检测、免疫学检测、药物滥用检测、细胞学检测和基因检测。2021 年，临床化学检测领域预计将占据市场主导地位，因为用于快速诊断疾病的即时检测解决方案的需求不断增加，预计将帮助市场大幅增长。
- 根据提供商，市场分为独立和参考实验室、医院实验室以及护理和医生办公室实验室。2021 年，医院实验室部门预计将占据市场主导地位，因为医院受伤病例不断增加，导致患者数量增加。
- 根据应用，市场细分为药物发现相关服务、药物开发相关服务、生物分析和实验室化学服务、毒理学检测服务、细胞和基因治疗相关服务、临床前和临床试验相关服务以及其他临床实验室服务。2021 年，生物分析和实验室化学服务领域预计将占据市场主导地位，因为实验室化学服务为化学分析提供支持，包括元素分析、故障分析和项目分析。
- 根据服务类型，市场分为常规检测服务、深奥服务和解剖病理学服务。由于研发需求不断增加，预计 2021 年常规检测服务领域将占据市场主导地位。
临床实验室服务市场国家层面分析
对临床实验室服务市场进行分析，并按上述国家专业、提供商、应用和服务类型提供市场规模信息。
临床实验室服务市场报告涵盖的国家包括南非、沙特阿拉伯、阿联酋、埃及、以色列以及中东和非洲的其他国家。
由于人们对疾病诊断和治疗认识的不断提高，南非有望主导临床实验室服务市场。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了中东和非洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
主要市场参与者不断增加的战略活动提高了人们对临床实验室服务的认识，从而推动了临床实验室服务市场的增长
临床实验室服务市场还提供了针对特定市场中每个国家增长情况的详细市场分析。此外，它还提供了有关市场参与者战略及其地理分布的详细信息。数据适用于 2010-2019 年的历史时期。
竞争格局和临床实验室服务市场份额分析
临床实验室服务市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对临床实验室服务市场的关注有关。
从事临床实验室服务的主要公司包括梅奥医学教育和研究基金会 (MFMER)、UNILABS、ACM 中东和非洲实验室以及雅培等国内公司。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。
全球各地的公司还发起了许多合同、协议、合作和发布，这也加速了临床实验室服务市场的发展。
例如，
- 2021年7月，人工智能（AI）癌症诊断的领先公司Deep Bio宣布与美国顶级参考实验室、全球创新实验室研发领导者ARUP Laboratories达成研究合作协议，此次合作将使公司在人工智能用于癌症诊断方面受益。
市场参与者的产品发布、业务扩展、奖励和认可、合资企业和其他策略正在扩大公司在临床实验室服务市场的影响力，这也为组织的利润增长带来了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 OVERVIEW OF ADJACENT BUSINESS
5.1 IMPACT OF POINT OF CARE TESTING MARKET ON CLINICAL LABORATORY TESTING MARKET
5.2 IMPACT OF BIOMETRIC SCREENING MARKET ON CLINICAL LABORATORY TESTING MARKET
5.3 IMPACT OF MOLECULAR DIAGNOSTICS MARKET ON CLINICAL LABORATORY TESTING MARKET
5.4 CONCLUSION
6 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: REGULATIONS
6.1 REGULATION IN THE U.S.
6.2 REGULATION IN EUROPE
6.3 REGULATIONS IN THAILAND
6.4 REGULATIONS IN DUBAI
6.5 REGULATIONS IN INDIA
6.6 REGULATIONS IN CHINA
6.7 REGULATIONS IN JAPAN
6.8 REGULATIONS IN SOUTH AFRICA
7 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: REIMBURSEMENTS
7.1 REIMBURSEMENT IN THE U.S. FOR CLINICAL LABORATORY SERVICES
7.2 REIMBURSEMENT IN INDIA FOR CLINICAL LABORATORY SERVICES
7.3 REIMBURSEMENT IN JAPAN FOR CLINICAL LABORATORY SERVICES
7.4 REIMBURSEMENT IN EUROPE FOR CLINICAL LABORATORY SERVICES
7.5 REIMBURSEMENT IN SOUTH AFRICA FOR CLINICAL LABORATORY SERVICES
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 RISE IN INFECTIOUS DISEASES WORLDWIDE
8.1.2 ADVANCEMENT IN CLINICAL DIAGNOSTIC METHODS
8.1.3 DEVELOPMENT IN DATABASE MANAGEMENT TOOLS AND WIDE ACCEPTANCE OF POINT-OF-CARE (POC) TESTING SOLUTIONS
8.1.4 RISE IN DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS
8.1.5 INCREASE IN APPLICATION OF HIGH-THROUGHPUT ASSAYS
8.2 RESTRAINTS
8.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
8.2.2 STRICT REGULATORY POLICIES
8.3 OPPORTUNITIES
8.3.1 INCREASE IN ADOPTION OF DIGITAL PATHOLOGY PLATFORMS
8.3.2 RISE IN PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS
8.3.3 INCREASE IN AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE
8.3.4 STRATEGIC INITIATIVES BY MARKET PLAYERS
8.4 CHALLENGES
8.4.1 INACCURATE RESULTS OF TESTS
8.4.2 INADEQUATE REIMBURSEMENTS POLICIES
9 IMPACT OF COVID-19 ON MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET
9.1 PRICE IMPACT
9.2 IMPACT ON DEMAND
9.3 IMPACT ON SUPPLY CHAIN
9.4 STRATEGIC DECISIONS FOR MANUFACTURERS
9.5 CONCLUSION
10 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE
10.1 OVERVIEW
10.2 ROUTINE TESTING SERVICES
10.2.1 ROUTINE CHEMISTRY TESTING
10.2.2 ROUTINE HEMATOLOGY TESTING
10.2.3 URINALYSIS TESTING
10.2.4 SUBSTANCE ABUSE TESTING
10.2.5 OTHERS
10.3 ESOTERIC SERVICES
10.4 ANATOMIC PATHOLOGY SERVICES
10.4.1 CYTOLOGY TESTING
10.4.2 DIAGNOSTIC SURGICAL PATHOLOGY TESTING
10.4.3 AUTOPSY PATHOLOGY
10.4.4 OTHERS
11 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY
11.1 OVERVIEW
11.2 CLINICAL CHEMISTRY TESTING
11.2.1 ROUTINE CHEMISTRY TESTING
11.2.2 THERAPEUTIC DRUG MONITORING (TDM) TESTING
11.2.3 SPECIALIZED CHEMISTRY TESTING
11.2.4 OTHER CLINICAL CHEMISTRY TESTING
11.3 HEMATOLOGY TESTING
11.3.1 ROUTINE HEMATOLOGY TESTING
11.3.2 SPECIALIZED HEMATOLOGY TESTING
11.3.3 COAGULATION TESTING
11.4 MICROBIOLOGY TESTING
11.4.1 INFECTIOUS DISEASE TESTING
11.4.2 TRANSPLANT DIAGNOSTIC TESTING
11.4.3 OTHER MICROBIOLOGY TESTING
11.5 IMMUNOLOGY TESTING
11.6 DRUGS OF ABUSE TESTING
11.7 CYTOLOGY TESTING
11.8 GENETIC TESTING
12 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER
12.1 OVERVIEW
12.2 HOSPITAL-BASED LABORATORIES
12.3 INDEPENDENT & REFERENCE LABORATORIES
12.4 NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES
13 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION
13.1 OVERVIEW
13.2 BIOANALYTICAL & LAB CHEMISTRY SERVICES
13.3 DRUG DEVELOPMENT RELATED SERVICES
13.4 DRUG DISCOVERY RELATED SERVICES
13.5 TOXICOLOGY TESTING SERVICES
13.6 CELL & GENE THERAPY RELATED SERVICES
13.7 PRECLINICAL & CLINICAL TRIAL RELATED SERVICES
13.8 OTHER CLINICAL LABORATORY SERVICES
14 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY REGION
14.1 MIDDLE EAST & AFRICA
14.1.1 SOUTH AFRICA
14.1.2 SAUDI ARABIA
14.1.3 U.A.E.
14.1.4 EGYPT
14.1.5 ISRAEL
14.1.6 REST OF MIDDLE EAST & AFRICA
15 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 LABORATORY CORPORATION OF AMERICA
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 SERVICE PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
17.2.1 COMPANY SNAPSHOT
17.2.2 COMPANY SHARE ANALYSIS
17.2.3 SERVICE PORTFOLIO
18.1.1 RECENT DEVELOPMENTS
18.2 DAVITA INC.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 SERVICE PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 QUEST DIAGNOSTICS INCORPORATED
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 SERVICE PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 SONIC HEALTHCARE
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 SERVICE PORTFOLIO
18.4.4 RECENT DEVELOPMENTS
18.5 ABBOTT
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 PRODUCT PORTFOLIO
18.5.4 RECENT DEVELOPMENTS
18.6 ACM MIDDLE EAST & AFRICA LABORATORIES
18.6.1 COMPANY SNAPSHOT
18.6.2 SERVICE PORTFOLIO
18.6.3 RECENT DEVELOPMENTS
18.7 AMEDES HOLDING GMBH
18.7.1 COMPANY SNAPSHOT
18.7.2 SERVICE PORTFOLIO
18.7.3 RECENT DEVELOPMENT
18.8 ARUP LABORATORIES
18.8.1 COMPANY SNAPSHOT
18.8.2 SERVICE PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 BIOREFERENCE LABORATORIES, INC. (A SUBSIDIARY OF OPKO HEALTH, INC.)
18.9.1 COMPANY SNAPSHOT
18.9.2 REVENUE ANALYSIS
18.9.3 SERVICE PORTFOLIO
18.9.4 RECENT DEVELOPMENTS
18.1 CHARLES RIVER
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 SERVICE PORTFOLIO
18.10.4 RECENT DEVELOPMENTS
18.11 EUROFINS SCIENTIFIC
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 SERVICE PORTFOLIO
18.11.4 RECENT DEVELOPMENTS
18.12 GENOMIC HEALTH
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENTS
18.13 H.U. GROUP HOLDINGS, INC.
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 SERVICE PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 KINGMED DIAGNOSTICS
18.14.1 COMPANY SNAPSHOT
18.14.2 SERVICE PORTFOLIO
18.14.3 RECENT DEVELOPMENTS
18.15 LIFELABS
18.15.1 COMPANY SNAPSHOT
18.15.2 SERVICE PORTFOLIO
18.15.3 RECENT DEVELOPMENTS
18.16 NEOGENOMICS LABORATORIES, INC.
18.16.1 COMPANY SNAPSHOT
18.16.2 REVENUE ANALYSIS
18.16.3 SERVICE PORTFOLIO
18.16.4 RECENT DEVELOPMENTS
18.17 SIEMENS HEALTHINEERS GMBH
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 SERVICE PORTFOLIO
18.17.4 RECENT DEVELOPMENTS
18.18 ,SYNLAB INTERNATIONAL GMBH (A SUBSIDIARY OF SYNLAB AG)
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 SERVICE PORTFOLIO
18.18.4 RECENT DEVELOPMENTS
18.19 NILABS
18.19.1 COMPANY SNAPSHOT
18.19.2 SERVICE PORTFOLIO
18.19.3 RECENT DEVELOPMENTS
19 QUESTIONNAIRE
20 RELATED REPORTS
表格列表
LIST OF TABLES
TABLE 1 NUMBER OF CORONAVIRUS (COVID-19) TESTS PERFORMED IN THE MOST IMPACTED COUNTRIES WORLDWIDE AS OF JULY 27, 2021
TABLE 2 TYPES AND RATES OF ERROR IN THE 3 STAGES OF THE LABORATORY TESTING PROCESS
TABLE 3 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST & AFRICA ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA ROUTINE TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA ESOTERIC SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA IMMUNOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA DRUGS OF ABUSE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA CYTOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA GENETIC TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA HOSPITAL-BASED LABORATORIES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA INDEPENDENT AND REFERENCE LABORATORIES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA NURSING AND PHYSICIAN OFFICE-BASED LABORATORIES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA BIOANALYTICAL AND LAB CHEMISTRY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA DRUG DEVELOPMENT RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA DRUG DISCOVERY RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA TOXICOLOGY TESTING SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA CELL AND GENE THERAPY RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA PRECLINICAL AND CLINICAL TRIAL RELATED SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA OTHER CLINICAL LABORATORY SERVICES IN CLINICAL LABORATORY SERVICES MARKET, BY REGION , 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 42 SOUTH AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 51 SAUDI ARABIA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 52 SAUDI ARABIA ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 53 SAUDI ARABIA ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 54 SAUDI ARABIA CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 55 SAUDI ARABIA CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 56 SAUDI ARABIA MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 57 SAUDI ARABIA HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 58 SAUDI ARABIA CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 59 SAUDI ARABIA CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 U.A.E. CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 61 U.A.E. ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 62 U.A.E. ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 63 U.A.E. CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 64 U.A.E. CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 65 U.A.E. MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 66 U.A.E. HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 67 U.A.E. CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 68 U.A.E. CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 69 EGYPT CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 70 EGYPT ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 71 EGYPT ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 72 EGYPT CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 73 EGYPT CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 74 EGYPT MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 75 EGYPT HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 76 EGYPT CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 77 EGYPT CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 78 ISRAEL CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 79 ISRAEL ROUTINE TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 80 ISRAEL ANATOMIC PATHOLOGY IN CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 81 ISRAEL CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 82 ISRAEL CLINICAL CHEMISTRY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 83 ISRAEL MICROBIOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 84 ISRAEL HEMATOLOGY TESTING IN CLINICAL LABORATORY SERVICES MARKET, BY SPECIALTY, 2019-2028 (USD MILLION)
TABLE 85 ISRAEL CLINICAL LABORATORY SERVICES MARKET, BY PROVIDER, 2019-2028 (USD MILLION)
TABLE 86 ISRAEL CLINICAL LABORATORY SERVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 87 REST OF MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, BY SERVICE TYPE, 2019-2028 (USD MILLION)
图片列表
LIST OF FIGURES
FIGURE 1 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: SEGMENTATION
FIGURE 11 RISING INFECTIOUS DISEASES WORLDWIDE AND RISING DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS ARE EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 ROUTINE TESTING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET
FIGURE 15 BELOW ARE BENEFITS THAT HAVE TO INCREASE THE ADOPTION OF DIGITAL PATHOLOGY PLATFORMS:
FIGURE 16 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2020
FIGURE 17 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, 2020-2028 (USD MILLION)
FIGURE 18 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, CAGR (2021-2028)
FIGURE 19 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE, LIFELINE CURVE
FIGURE 20 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2020
FIGURE 21 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, 2020-2028 (USD MILLION)
FIGURE 22 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, CAGR (2021-2028)
FIGURE 23 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SPECIALTY, LIFELINE CURVE
FIGURE 24 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2020
FIGURE 25 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, 2020-2028 (USD MILLION)
FIGURE 26 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, CAGR (2020-2028)
FIGURE 27 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY PROVIDER, LIFELINE CURVE
FIGURE 28 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2020
FIGURE 29 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 30 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, CAGR (2020-2028)
FIGURE 31 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 32 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: SNAPSHOT (2020)
FIGURE 33 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY COUNTRY (2020)
FIGURE 34 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 35 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 36 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: BY SERVICE TYPE (2021 & 2028)
FIGURE 37 MIDDLE EAST & AFRICA CLINICAL LABORATORY SERVICES MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
